Introduction This study tested the hypothesis that cyclosporine (CsA)-supported syngeneic
adipose-derived mesenchymal stem cell (ADMSC) therapy offered superior attenuation of …

Background Reactive oxygen species are important mediators exerting toxic effects on
various organs during ischemia-reperfusion (IR) injury. We hypothesized that adipose …

Acute kidney injury (AKI) is a complex clinical condition associated with significant morbidity
and mortality and lacking effective management. Ischemia‑reperfusion injury (IRI) remains …

Stem cells therapy has been suggested as a promising option for the treatment of acute
kidney injury (AKI). This study was performed to compare the abilities of xenogenic …

Acute kidney injury (AKI) represents a group of complicated syndromes with a high mortality
rate. The administration of adipose‐derived mesenchymal stem cells (ADMSC s) has been …

Background In this study, we tested the hypothesis that a combined adipose-derived
mesenchymal stem cell (ADMSC) and ADMSC-derived exosome therapy protected rat …

This study tested the hypothesis that combined therapy with exendin-4 (Ex4) and autologous
adipose-derived mesenchymal stem cells (ADMSCs) was superior to either alone for …

Objective (s): It has been shown that adipose-derived mesenchymal stem cells (AD-MSC)
have protective effects in acute kidney injury (AKI). This study was conducted to assess the …

Background. Acute kidney injury (AKI) represents a major clinical problem with high mortality
and limited causal treatments. The use of cell therapy has been suggested as a potential …

It has been shown that administration of adipose derived mesenchymal stem cells
(AdMSCs) enhanced structural and functional recovery of renal ischemia‐reperfusion (IR) …